- Home
- NKTX vs PHH Comparison
NKTX vs PHH Comparison
Compare NKTX & PHH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NKTX
- PHH
- Stock Information
- Founded
- NKTX 2015
- PHH 2016
- Country
- NKTX United States
- PHH China
- Employees
- NKTX N/A
- PHH N/A
- Industry
- NKTX Biotechnology: Pharmaceutical Preparations
- PHH Package Goods/Cosmetics
- Sector
- NKTX Health Care
- PHH Consumer Discretionary
- Exchange
- NKTX Nasdaq
- PHH Nasdaq
- Market Cap
- NKTX 170.8M
- PHH 160.1M
- IPO Year
- NKTX 2020
- PHH 2024
- Fundamental
- Price
- NKTX $2.05
- PHH $5.44
- Analyst Decision
- NKTX Strong Buy
- PHH
- Analyst Count
- NKTX 5
- PHH 0
- Target Price
- NKTX $15.20
- PHH N/A
- AVG Volume (30 Days)
- NKTX 853.6K
- PHH 41.8K
- Earning Date
- NKTX 03-20-2025
- PHH 01-01-0001
- Dividend Yield
- NKTX N/A
- PHH N/A
- EPS Growth
- NKTX N/A
- PHH N/A
- EPS
- NKTX N/A
- PHH 0.02
- Revenue
- NKTX N/A
- PHH $1,940,443.00
- Revenue This Year
- NKTX N/A
- PHH N/A
- Revenue Next Year
- NKTX N/A
- PHH N/A
- P/E Ratio
- NKTX N/A
- PHH $357.67
- Revenue Growth
- NKTX N/A
- PHH 108.42
- 52 Week Low
- NKTX $1.96
- PHH $3.70
- 52 Week High
- NKTX $16.24
- PHH $6.90
- Technical
- Relative Strength Index (RSI)
- NKTX 39.74
- PHH N/A
- Support Level
- NKTX $1.96
- PHH N/A
- Resistance Level
- NKTX $2.35
- PHH N/A
- Average True Range (ATR)
- NKTX 0.15
- PHH 0.00
- MACD
- NKTX -0.00
- PHH 0.00
- Stochastic Oscillator
- NKTX 19.15
- PHH 0.00
About NKTX Nkarta Inc.
Nkarta Inc is a biopharmaceutical company engaged in developing engineered natural killer (NK) cells to treat cancer and autoimmune diseases. The Company is engaged in leveraging the natural potent power of NK cells to identify and kill abnormal cells and recruit adaptive immune effectors to generate responses that are specific and durable. The company is combining its NK expansion platform technology with proprietary cell engineering technologies to generate an abundant supply of NK cells, engineer enhanced NK cell recognition of therapeutic targets, and improve persistence for sustained activity in the body for the treatment of cancer. The Company's operations are based in South San Francisco, California.
About PHH Park Ha Biological Technology Co. Ltd. Ordinary Shares
Park Ha Biological Technology Co Ltd is engaged in developing its private skincare label, direct skincare products sales and franchise alliances promotions. Its Park Ha brand focuses on providing solutions for problematic skin. The company's Operating Subsidiaries specialize in providing skincare and cosmetic products under its brand name Park Ha in China. Its Operating Subsidiaries develop its proprietary beauty products and offer complimentary after-sales beauty services in its physical stores.